1. Home
  2. SII vs PLSE Comparison

SII vs PLSE Comparison

Compare SII & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SII
    SELLHOLDBUYas of 3 days ago
  • PLSE
    SELLHOLDBUYas of 3 days ago
  • Stock Information
  • Founded
  • SII 2008
  • PLSE 2014
  • Country
  • SII Canada
  • PLSE United States
  • Employees
  • SII N/A
  • PLSE N/A
  • Industry
  • SII Finance: Consumer Services
  • PLSE Medical/Dental Instruments
  • Sector
  • SII Finance
  • PLSE Health Care
  • Exchange
  • SII Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • SII 1.1B
  • PLSE 1.3B
  • IPO Year
  • SII N/A
  • PLSE 2016
  • Fundamental
  • Price
  • SII $40.65
  • PLSE $15.08
  • Analyst Decision
  • SII
  • PLSE
  • Analyst Count
  • SII 0
  • PLSE 0
  • Target Price
  • SII N/A
  • PLSE N/A
  • AVG Volume (30 Days)
  • SII 149.1K
  • PLSE 235.3K
  • Earning Date
  • SII 05-07-2025
  • PLSE 05-06-2025
  • Dividend Yield
  • SII 2.95%
  • PLSE N/A
  • EPS Growth
  • SII 19.38
  • PLSE N/A
  • EPS
  • SII 1.91
  • PLSE N/A
  • Revenue
  • SII $178,655,000.00
  • PLSE N/A
  • Revenue This Year
  • SII N/A
  • PLSE N/A
  • Revenue Next Year
  • SII $8.66
  • PLSE N/A
  • P/E Ratio
  • SII $21.32
  • PLSE N/A
  • Revenue Growth
  • SII 18.03
  • PLSE N/A
  • 52 Week Low
  • SII $38.41
  • PLSE $6.60
  • 52 Week High
  • SII $48.00
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • SII 34.67
  • PLSE 38.22
  • Support Level
  • SII $42.77
  • PLSE $15.29
  • Resistance Level
  • SII $45.40
  • PLSE $16.80
  • Average True Range (ATR)
  • SII 1.33
  • PLSE 1.14
  • MACD
  • SII -0.28
  • PLSE 0.01
  • Stochastic Oscillator
  • SII 8.59
  • PLSE 32.18

Stock Price Comparison Chart: SII vs PLSE

SII
PLSE
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April051015202530354045505560SII VS PLSE

About SII Sprott Inc.

Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use